Skip to Main Content

Author Details

Ying Ma
National Institutes of Health
1994
128
41
PMIDPaper TitleJournal TitlePublished Year
35606352A genetic engineering strategy for editing near-infrared-II fluorophores.Nat Commun2022
34210986Author Correction: Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death.Nat Commun2021
32550894Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery.Theranostics2020
31877023Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.ACS Nano2020
33310853Size-transformable antigen-presenting cell-mimicking nanovesicles potentiate effective cancer immunotherapy.Sci Adv2020
33206522Reactive Oxygen Species Activatable Heterodimeric Prodrug as Tumor-Selective Nanotheranostics.ACS Nano2020
32656801Targeting Neutrophils for Enhanced Cancer Theranostics.Adv Mater2020
33009382Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death.Nat Commun2020
30300471Antidiabetic Effect of Abextide, a Long-Acting Exendin-4 Analogue in Cynomolgus Monkeys.Adv Healthc Mater2019
31244923Core-shell metal-organic frameworks with fluorescence switch to trigger an enhanced photodynamic therapy.Theranostics2019
31181890Improving the Theranostic Potential of Exendin 4 by Reducing the Renal Radioactivity through Brush Border Membrane Enzyme-Mediated Degradation.Bioconjug Chem2019
31317730Tumor Microenvironment-Activated Ultrasensitive Nanoprobes for Specific Detection of Intratumoral Glutathione by Ratiometric Photoacoustic Imaging.ACS Appl Mater Interfaces2019
31374171Organosilica-Based Hollow Mesoporous Bilirubin Nanoparticles for Antioxidation-Activated Self-Protection and Tumor-Specific Deoxygenation-Driven Synergistic Therapy.ACS Nano2019
314022033-<sup>18</sup>F-fluoropropane-1-thiol and <sup>18</sup>F-PEG<sub>4</sub>-1-thiol: Versatile prosthetic groups for radiolabeling maleimide functionalized peptides.Bioorg Med Chem2019
30867836A Logic-Gated Modular Nanovesicle Enables Programmable Drug Release for On-Demand Chemotherapy.Theranostics2019
31117347An Albumin-Binding T<sub>1</sub>- T<sub>2</sub> Dual-Modal MRI Contrast Agents for Improved Sensitivity and Accuracy in Tumor Imaging.Bioconjug Chem2019
30886808Tumor-Specific Drug Release and Reactive Oxygen Species Generation for Cancer Chemo/Chemodynamic Combination Therapy.Adv Sci (Weinh)2019
31082207An Albumin Sandwich Enhances in Vivo Circulation and Stability of Metabolically Labile Peptides.Bioconjug Chem2019
30575388Ratiometric Photoacoustic Nanoprobe for Bioimaging of Cu<sup>2</sup>.ACS Appl Mater Interfaces2019
29344302Evans Blue Attachment Enhances Somatostatin Receptor Subtype-2 Imaging and Radiotherapy.Theranostics2018
30105912Single Low-Dose Injection of Evans Blue Modified PSMA-617 Radioligand Therapy Eliminates Prostate-Specific Membrane Antigen Positive Tumors.Bioconjug Chem2018
29738963Purification of R-phycoerythrin from Gracilaria lemaneiformis by centrifugal precipitation chromatography.J Chromatogr B Analyt Technol Biomed Life Sci2018
29624828Polymeric Nanoparticles with a Glutathione-Sensitive Heterodimeric Multifunctional Prodrug for In Vivo Drug Monitoring and Synergistic Cancer Therapy.Angew Chem Int Ed Engl2018
29456156A multilayer coil in type-I counter-current chromatography.J Chromatogr A2018
29556370A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.Theranostics2018
29254329Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN<sub>7-14</sub> and Antagonist RM26.Bioconjug Chem2018
27879373Novel "Add-On" Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents.J Nucl Med2017
28224711Ratiometric Photoacoustic Molecular Imaging for Methylmercury Detection in Living Subjects.Adv Mater2017
28277675Correction to "Novel <sup>19</sup>F Activatable Probe for the Detection of Matrix Metalloprotease-2 Activity by MRI/MRS".Mol Pharm2017
29203865Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy.Nat Commun2017
29176623Microneedle-array patches loaded with dual mineralized protein/peptide particles for type 2 diabetes therapy.Nat Commun2017
28858467Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy.ACS Nano2017
28744320Quantification of Tumor Vascular Permeability and Blood Volume by Positron Emission Tomography.Theranostics2017
26818100Combined image guided monitoring the pharmacokinetics of rapamycin loaded human serum albumin nanoparticles with a split luciferase reporter.Nanoscale2016
26641886Stable Evans Blue Derived Exendin-4 Peptide for Type 2 Diabetes Treatment.Bioconjug Chem2016
27149392A photothermally responsive nanoprobe for bioimaging based on Edman degradation.Nanoscale2016
26877782Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding.Theranostics2016
25698784PET imaging of tenascin-C with a radiolabeled single-stranded DNA aptamer.J Nucl Med2015
26568270A novel self-assembled sandwich nanomedicine for NIR-responsive release of NO.Nanoscale2015
26382146Protein-based photothermal theranostics for imaging-guided cancer therapy.Nanoscale2015
2631583618F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.J Nucl Med2015
26086295Novel Method for Radiolabeling and Dimerizing Thiolated Peptides Using (18)F-Hexafluorobenzene.Bioconjug Chem2015
25976126Fabrication of chiral amino acid ionic liquid modified magnetic multifunctional nanospheres for centrifugal chiral chromatography separation of racemates.J Chromatogr A2015
23982795Comparison of three dimeric 18F-AlF-NOTA-RGD tracers.Mol Imaging Biol2014
25476690Enantioseparation of (DL)-tryptophan by spiral tube assembly counter-current chromatography and evaluation of mass transfer rate for enantiomers.J Chromatogr A2014
25285166Quantitative proteomics analysis identifies mitochondria as therapeutic targets of multidrug-resistance in ovarian cancer.Theranostics2014
25224367PET and NIR optical imaging using self-illuminating (64)Cu-doped chelator-free gold nanoclusters.Biomaterials2014
25271556Novel 19F activatable probe for the detection of matrix metalloprotease-2 activity by MRI/MRS.Mol Pharm2014
24842890In Vivo Labeling of Serum Albumin for PET.J Nucl Med2014
24798315One-pot two-step radiosynthesis of a new (18)F-labeled thiol reactive prosthetic group and its conjugate for insulinoma imaging.Mol Pharm2014
  • 1 - 50 of 128

Recommended Authors

University of California san francisco
Career Start Year 2014
Number of shared co-authors 0
UT MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 1
Ontario Institute for Cancer Research, University Avenue
Career Start Year 2007
Number of shared co-authors 0
University of Michigan Medical School ann arbor
Career Start Year 2007
Number of shared co-authors 2
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year 2005
Number of shared co-authors 0
Career Start Year 2003
Number of shared co-authors 0
Hefei National Laboratory, University of Science and Technology of China
Career Start Year 2002
Number of shared co-authors 3
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
College of Plant Protection, Southwest University
Career Start Year 2001
Number of shared co-authors 0
Oncology R&D
Career Start Year 1998
Number of shared co-authors 0
Karolinska Institutet
Career Start Year 1998
Number of shared co-authors 0
MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 0
The University of Danang-University of Science and Technology
Career Start Year 1993
Number of shared co-authors 0
Blavatnik Institute, Harvard Medical School
Career Start Year 1990
Number of shared co-authors 0
St. George's University Medical School
Career Start Year 1990
Number of shared co-authors 1
University of Illinois at Urbana-Champaign
Career Start Year 1990
Number of shared co-authors 0
Departamento de Toxicologia y Farmacologia Preclinica
Career Start Year 1989
Number of shared co-authors 0
University Medical Center Hamburg-Eppendorf
Career Start Year 1989
Number of shared co-authors 0
Division of Pharmacy and Optometry, University of Manchester
Career Start Year 1988
Number of shared co-authors 0
ReNeuroGen LLC
Career Start Year 1985
Number of shared co-authors 0
University of Washington School of Medicine
Career Start Year 1984
Number of shared co-authors 0
University of Texas Health Science Center at San Antonio Texas78229 USA.
Career Start Year 1973
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 1972
Number of shared co-authors 0
Wake Forest University School of Medicine
Career Start Year 1972
Number of shared co-authors 1
Monash University
Career Start Year 1971
Number of shared co-authors 0
Suzhou Institute of Nano-Tech and Nano-Bionics (SINANO), Chinese Academy of Sciences
Career Start Year 1969
Number of shared co-authors 1
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1968
Number of shared co-authors 1
College of Medicine, The Ohio State University
Career Start Year 1967
Number of shared co-authors 0

Collaborators

Institute of Molecular and Cell Biology
Co-authored papers 80
National Institute of Biomedical Imaging and Bioengineering
Co-authored papers 62
The First Affiliated Hospital of Xi'an Jiaotong University
Co-authored papers 59
First Hospital of Shanxi Medical University, Shanxi Medical University
Co-authored papers 42
Emory University School of Medicine
Co-authored papers 19
Beijing Tongren Hospital, Capital Medical University
Co-authored papers 9
The Johns Hopkins University School of Medicine
Co-authored papers 6
Yale University
Co-authored papers 5
Co-authored papers 5
The Second Hospital of Dalian Medical University
Co-authored papers 4
College of Clinical Medicine, Jining Medical University
Co-authored papers 3
National Institutes of Health
Co-authored papers 2
University of California San Diego.
Co-authored papers 2
Co-authored papers 2
Massachusetts General Hospital, Harvard Medical School
Co-authored papers 1
College of Life Science and Technology, Huazhong University of Science and Technology
Co-authored papers 1
Massachusetts General Hospital
Co-authored papers 1
National Institutes of Health
Co-authored papers 1
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Sichuan University
Co-authored papers 1
Co-authored papers 1
Institute for Biodiagnostics, National Research Council Canada
Co-authored papers 1
Keck School of Medicine of USC
Co-authored papers 1